Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

All Drug Marketing Is Local
WSJ
Saturday, October 1, 2011 - 1:52pm
tags:
marketing
This Week in Biotech
Motley Fool
Saturday, October 1, 2011 - 1:50pm
tags:
Pharmasset, GSK, Human Genome Sciences, Vertex Pharmaceuticals, Optimer Pharmaceuticals, Cubist Pharmaceuticals, Array Biopharma, AstraZeneca
Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Trial of SB-509 in Diabetic Neuropathy
Yahoo/PR NewsWire
Saturday, October 1, 2011 - 1:47pm
tags:
Sangamo BioSciences, diabetic neuropathy, SB-509
ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA
Yahoo/PR NewsWire
Saturday, October 1, 2011 - 12:48pm
tags:
Adventrx, Exelbine, non-small cell lung cancer
Momenta Pharmaceuticals Files for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.
Yahoo/GlobeNewswire
Saturday, October 1, 2011 - 12:47pm
tags:
Momenta, Amphastar, International Medical Systems, Watson Pharmaceuticals, patents, Patent Infringement
ITMN's Esbriet Safe Long Term
Yahoo/Zacks
Saturday, October 1, 2011 - 12:45pm
tags:
InterMune, Esbriet, idiopathic pulmonary fibrosis
Patent Trolling Is Taking Its Toll On Biotech
Seeking Alpha
Saturday, October 1, 2011 - 12:44pm
tags:
Classen Immunotherapies, patents
The Real Winners of $1,000 Exomes
Motley Fool
Saturday, October 1, 2011 - 12:42pm
tags:
23andMe, Google, Illumina, genome sequencing
Agenus Announces Reverse Stock Split
Yahoo/GlobeNewswire
Saturday, October 1, 2011 - 12:39pm
tags:
Agenus
Vical's Allovectin-7: Are The Phase 3 Trial Results Hiding In Plain Sight?
Seeking Alpha
Saturday, October 1, 2011 - 12:36pm
tags:
Vical, Allovectin-7
How Quickly Is the Cash Coming at Illumina?
Motley Fool
Saturday, October 1, 2011 - 12:35pm
tags:
Illumina
Human Genome slides on U.K. setback
MarketWatch
Saturday, October 1, 2011 - 12:34pm
tags:
Human Genome Sciences, lupus, Benlysta
FDA Biosimilar Guidelines Complete, Awaiting Publication
Patent Docs
Friday, September 30, 2011 - 12:20pm
tags:
FDA, biosimilars
Human Genome Sciences stock falls as Britain denies funding for Benlysta
Bizjournals.com
Friday, September 30, 2011 - 12:11pm
tags:
Human Genome Sciences, UK, Benlysta, lupus, GSK
Takeda Completes Acquisition and Names New CEO of Nycomed
PR Newswire
Friday, September 30, 2011 - 12:09pm
tags:
Takeda, Nycomed, M&A
Pfizer, Roche, Novartis lead the way for Big Pharma in Japan
Fierce Pharma
Friday, September 30, 2011 - 12:03pm
tags:
Japan, Pfizer, Roche, Novartis
Pharmasset Shares Surge on New Hep C Data
TheStreet.com
Friday, September 30, 2011 - 12:02pm
tags:
Pharmasset, hepatitis C, PSI-7977
Investors Guide to the New PDUFA
Motley Fool
Friday, September 30, 2011 - 11:16am
tags:
PDUFA, investors
ViroPharma pays Intellect Neurosciences $6.5 million for drug molecule rights
Yahoo/AP
Friday, September 30, 2011 - 11:10am
tags:
ViroPharma, Intellect Neurosciences, Friedreich's Ataxia, OX1
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Yahoo/AP
Friday, September 30, 2011 - 11:09am
tags:
Array, lung cancer, selumetinib, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.